Crossmark

GPI‑anchored protein nanoclusters license migrasome expansion and serve as exocytic platforms for migrasome

Published Online: 2026-06-04

Authors

Li, Xiaopeng

Li, Ying https://orcid.org/0000-0003-4080-3214
Xie, Renxiang https://orcid.org/0000-0003-4194-3016
Jiao, Haifeng https://orcid.org/0009-0007-4235-6995
Yu, Li https://orcid.org/0000-0002-3757-0758
License Information

Text and Data Mining valid from 2026-06-04

Accepted Manuscript valid from 2026-06-04
More Information

Article History

Received: 5 November 2025

Accepted: 12 May 2026

First Online: 4 June 2026

Competing interests

: Li Yu is the scientific founder of Migrasome Therapeutics Ltd. All other authors declare no conflicts of interest.

Document is current